Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

ACC's October Board of Trustees (BOT) meeting was rich with strategic dialogue and forward-looking initiatives that reflect our shared commitment to advancing cardiovascular care and strengthening the ...

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options ...

Consumption of ultra-processed foods, such as sugar-sweetened beverages, breads, potato chips and packaged cookies, may be associated with adverse health outcomes, including hypertension, cancer, ...

The ACC is excited to announce that two of its JACC Journals – JACC: Asia and JACC: Advances – will receive an official Impact Factor, with the first rankings being issued in June 2026 as part of the ...

In this week’s View, Dr. Eagle looks at the social drivers behind the rise in heart disease mortality in California. He then explores the prevalence of preexisting cardiometabolic comorbidities and ...

Findings from the PREVUE-VALVE study presented at TCT 2025 shed light on the prevalence of valvular heart disease (VHD) and its subtypes among older Americans, as well as the influence of age, sex, ...

The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

Among low-risk patients with severe, symptomatic aortic stenosis who underwent either TAVR or surgery, the incidence of death, stroke or rehospitalization at seven years was similar across both groups ...

Get coverage of important new developments in cardiology ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Using real-world outcomes data from the STS/ACC TVT Registry, findings from the EVOQUE study presented at TCT 2025 demonstrate favorable safety and effectiveness of transcatheter tricuspid valve ...